Cimpress plc CMPR
79.79
1.18
1.50%
as of 25 Sep
- Market cap
- $1.9B
- P/E
- 20.4×
Follow CMPR
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
44.71 | 68.65 | 39.04 | 25.94 |
P/S ratio |
0.45 | 0.46 | 0.48 | 0.66 | |
P/FCF ratio |
9.45 | 10.58 | 13.54 | 19.05 | |
P/Operating CF |
61.82 | 9.94 | (107.19) | 22.48 | |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.85 | 0.83 | 0.87 | 1.01 | |
EV/EBITDA |
7.77 | 7.68 | 7.96 | 9.37 | |
EV/Operating CF |
9.22 | 9.68 | 11.30 | 13.30 | |
EV/FCF |
17.93 | 19.21 | 24.25 | 28.94 | |
Quick Ratio |
0.37 | 0.40 | 0.36 | 0.42 | |
Current Ratio |
0.65 | 0.68 | 0.68 | 0.73 | |
Net Debt/EBITDA |
16.05 | 10.58 | 16.01 | 12.03 | |
Debt/Assets |
80.03% | 75.33% | 76.65% | 72.52% | |
Debt/Equity |
(2.76) | (2.98) | (3.01) | (3.37) | |
Asset Turnover |
1.80 | 1.78 | 1.86 | 1.79 | |
Operating CF/Net income |
3.28 | 3.34 | (1.19) | 4.41 | |
Capex/Depreciation |
(1.17) | (1.10) | (1.02) | (0.97) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
9.83% | 8.55% | 9.80% | 9.70% | |
Selling, General and Administrative Expense of Revenue |
30.63% | 29.40% | 30.18% | 28.35% | |
Intangible Assets out of Total Assets |
0.45 | 0.42 | 0.42 | 0.42 | |
Share Based Compensation of Revenue |
1.71% | 1.61% | 1.65% | 1.60% | |
Graham Net Nets |
(1.32) | (1.26) | (1.18) | (0.85) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
2.24% | 1.46% | 2.56% | 3.85% | |
Free Cash Flow Yield |
10.58% | 9.45% | 7.39% | 5.25% | |
Revenue per Share |
35.13 | 42.42 | 36.53 | 38.69 | |
Operating CF per Share |
1.02 | 6.70 | (0.68) | 4.52 | |
Capex per Share |
(1.74) | (1.64) | (1.57) | (1.64) | |
Free Cash Flow per Share |
(0.72) | 5.06 | (2.25) | 2.89 | |
Cash per Share |
8.16 | 10.50 | 7.79 | 13.20 | |
Shareholders Equity per Share |
(23.22) | (21.57) | (21.60) | (19.40) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(23.22) | (21.57) | (21.60) | (19.40) | |
Free Cash Flow |
(17.76) | 124.33 | (54.62) | 70.48 | |
Working Capital |
(265.37) | (264.92) | (234.19) | (211.14) | |
Capital Expenditures |
(42.82) | (40.33) | (38.10) | (40.03) | |
Net Current Asset Value |
(2,047.96) | (2,063.24) | (2,083.20) | (2,111.90) | |
EV/EBIT |
12.45 | 12.22 | 12.60 | 15.03 | |
Capex to Sales |
0.05 | 0.04 | 0.04 | 0.04 | |
Net Profit Margin |
0.88% | 4.73% | 1.56% | 2.65% | |
Price to Operating Income |
6.57 | 6.73 | 7.04 | 9.90 | |
| Other line items | |||||
Average Receivables |
76.24 | 64.73 | 69.40 | — | |
Average Payables |
307.84 | 347.25 | 303.66 | 332.68 | |
Average Inventory |
114.96 | 113.03 | 112.86 | 124.93 | |
Average Assets |
1,925.24 | 2,006.14 | 1,966.61 | 2,085.33 | |
Average Common Equity |
(570.48) | (541.86) | (540.34) | (528.17) |
Columns are period end dates